Mentoring Diabetes Research in Oklahoma

$997,203P20FY2009RRNIH

University Of Oklahoma Hlth Sciences Ctr, Oklahoma City OK

Investigators

Linked publications & trials

Paper 33107777 Paper 32941882 Paper 31884656 Paper 31884604 Paper 29943190 Paper 29721978 Paper 29687558 Paper 27484451 Paper 27475954 Paper 27429802 Paper 27367504 Paper 26111446 Paper 26055327 Paper 25912764 Paper 25858560 Paper 25663658 Paper 25657312 Paper 25403501 Paper 25293868 Paper 25062003 Paper 25016145 Paper 24853093 Paper 24717912 Paper 24670970 Paper 24616481 Paper 24513079 Paper 24463424 Paper 24345049 Paper 24337247 Paper 24302004 Paper 24274545 Paper 23842729 Paper 23770348 Paper 23507223 Paper 23464925 Paper 23458165 Paper 23406904 Paper 23380689 Paper 23353086 Paper 23319544 Paper 23275801 Paper 23223177 Paper 23211829 Paper 23071093 Paper 23066786 Paper 23056421 Paper 23043158 Paper 23030792 Paper 23028906 Paper 23027442 Paper 22967499 Paper 22935961 Paper 22930782 Paper 22915031 Paper 22891217 Paper 22817137 Paper 22772755 Paper 22715395 Paper 22678501 Paper 22666560 Paper 22645143 Paper 22587821 Paper 22574218 Paper 22512451 Paper 22438226 Paper 22272240 Paper 22228718 Paper 22215709 Paper 22183346 Paper 22130180 Paper 22016045 Paper 22015457 Paper 21996664 Paper 21782811 Paper 21778754 Paper 21754923 Paper 21685727 Paper 21676174 Paper 21576363 Paper 21551411 Paper 21545396 Paper 21446919 Paper 21421629 Paper 21360191 Paper 21357401 Paper 21281801 Paper 21253511 Paper 21235714 Paper 21178141 Paper 21139979 Paper 21138840 Paper 21134994 Paper 20978740 Paper 20948845 Paper 20876139 Paper 20530741 Paper 20529977 Paper 20484052 Paper 20351274 Paper 20348234

Abstract

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. For research to develop targeted treatments and preventive measures for diabetic retinopathy, the most common cause of blindness in working-age adults in the developed world.

View original record on NIH RePORTER →